HUM Humana Inc. Common Stock
O Humana Inc. Common Stock Przegląd firmy z Wikipedii
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
Czytaj więcej
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
HUM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
HUM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 26 czerwca 2026 | $0,8850 |
| 27 marca 2026 | $0,8850 |
| 26 grudnia 2025 | $0,8850 |
| 26 września 2025 | $0,8850 |
| 27 czerwca 2025 | $0,8850 |
| 28 marca 2025 | $0,8850 |
| 31 grudnia 2024 | $0,8850 |
| 30 września 2024 | $0,8850 |
| 28 czerwca 2024 | $0,8850 |
| 27 marca 2024 | $0,8850 |
| 28 grudnia 2023 | $0,8850 |
| 28 września 2023 | $0,8850 |
| 29 czerwca 2023 | $0,8850 |
| 30 marca 2023 | $0,8850 |
| 29 grudnia 2022 | $0,7880 |
| 29 września 2022 | $0,7880 |
| 29 czerwca 2022 | $0,7880 |
| 30 marca 2022 | $0,7880 |
| 30 grudnia 2021 | $0,7000 |
| 29 września 2021 | $0,7000 |
HUM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 8 24,2%
- Kup 8 24,2%
- Trzymaj 15 45,5%
- Sprzedaj 2 6,1%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
23 analityków · 2026-08-19Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $7.61 | $7.29 | 0.32% |
| 31 marca 2026 | $10.31 | $10.29 | 0.02% |
| 31 grudnia 2025 | $-3.96 | $-4.05 | 0.09% |
| 30 września 2025 | $3.24 | $2.85 | 0.39% |
| 30 czerwca 2025 | $6.27 | $5.98 | 0.29% |
| 31 marca 2025 | $11.58 | $10.17 | 1.4% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Wycena (TTM) 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Marża Operacyjna % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Zysk netto | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| Rozwodniony EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Wskaźnik bieżący | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Wskaźnik Szybkości | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $375M | $2.39B | $2.98B | $3.47B | $946M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 050 emitentów · $33.7B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 255 (+143 vs poprzedni kw.) | 81 (-80 vs poprzedni kw.) | 313 (+42 vs poprzedni kw.) | 273 (-45 vs poprzedni kw.) | +23.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Dodge & Cox | $4 345 737 744 | 10 940 380 | 12,90% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 115 642 737 | 7 843 620 | 9,25% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 311 405 702 | 5 818 956 | 6,86% | Akcje |
| STATE STREET CORP | $2 172 441 313 | 5 457 072 | 6,45% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $1 528 010 749 | 3 846 762 | 4,54% | Akcje |
| Sessa Capital IM, L.P. | $1 480 732 883 | 3 727 740 | 4,40% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 181 074 714 | 2 976 242 | 3,51% | Akcje |
| Capital International Investors | $950 462 637 | 2 392 826 | 2,82% | Akcje |
| NAYA CAPITAL MANAGEMENT UK LTD | $728 407 339 | 1 833 763 | 2,16% | Akcje |
| NORGES BANK | $694 505 009 | 1 748 414 | 2,06% | Akcje |
| GOLDMAN SACHS GROUP INC | $659 096 868 | 1 659 274 | 1,96% | Akcje |
| FMR LLC | $615 633 048 | 1 549 854 | 1,83% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544 502 820 | 1 370 784 | 1,62% | Akcje |
| Capital Research Global Investors | $443 462 035 | 1 116 990 | 1,32% | Akcje |
| Slate Path Capital LP | $428 969 795 | 1 079 930 | 1,27% | Akcje |
| Capital World Investors | $406 119 738 | 1 022 425 | 1,21% | Akcje |
| Newport Trust Company, LLC | $384 768 345 | 968 653 | 1,14% | Akcje |
| CITADEL ADVISORS LLC | $363 376 856 | 914 800 | 1,08% | Opcja kupna |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348 908 912 | 878 377 | 1,04% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $331 490 508 | 834 526 | 0,98% | Akcje |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314 921 577 | 792 814 | 0,93% | Akcje |
| CITADEL ADVISORS LLC | $310 904 094 | 782 700 | 0,92% | Opcja sprzedaży |
| WELLINGTON MANAGEMENT GROUP LLP | $282 117 958 | 710 231 | 0,84% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $267 791 027 | 674 163 | 0,79% | Akcje |
| Maple Rock Capital Partners Inc. | $249 553 862 | 628 251 | 0,74% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245 555 446 | 618 185 | 0,73% | Akcje |
| GOLDMAN SACHS GROUP INC | $232 333 978 | 584 900 | 0,69% | Opcja kupna |
| MARSHALL WACE, LLP | $216 873 381 | 545 978 | 0,64% | Akcje |
| CITADEL ADVISORS LLC | $178 080 082 | 448 316 | 0,53% | Akcje |
| High Ground Investment Management LLP | $177 941 848 | 447 968 | 0,53% | Akcje |
| 1832 Asset Management L.P. | $176 401 430 | 444 090 | 0,52% | Akcje |
| BCV Asset Management Inc. | $173 695 656 | 445 719 | 0,52% | Akcje |
| BANK OF AMERICA CORP /DE/ | $172 703 708 | 434 781 | 0,51% | Akcje |
| Holocene Advisors, LP | $165 040 541 | 415 489 | 0,49% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $147 490 964 | 371 308 | 0,44% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $140 098 700 | 352 698 | 0,42% | Akcje |
| JANE STREET GROUP, LLC | $137 080 622 | 345 100 | 0,41% | Opcja kupna |
| Swiss National Bank | $134 522 525 | 338 660 | 0,40% | Akcje |
| JANE STREET GROUP, LLC | $122 542 370 | 308 500 | 0,36% | Opcja sprzedaży |
| STEADFAST CAPITAL MANAGEMENT LP | $122 423 204 | 308 200 | 0,36% | Akcje |
| BlackRock, Inc. | $120 890 332 | 304 341 | 0,36% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115 565 201 | 290 935 | 0,34% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $109 135 401 | 274 748 | 0,32% | Akcje |
| AMERIPRISE FINANCIAL INC | $108 302 217 | 272 614 | 0,32% | Akcje |
| Legal & General Group Plc | $103 424 967 | 260 372 | 0,31% | Akcje |
| Vanguard Global Advisers, LLC | $103 330 825 | 260 135 | 0,31% | Akcje |
| GOLDMAN SACHS GROUP INC | $103 078 590 | 259 500 | 0,31% | Opcja sprzedaży |
| NEUBERGER BERMAN GROUP LLC | $102 585 352 | 258 258 | 0,30% | Akcje |
| BANK OF NOVA SCOTIA | $102 313 941 | 257 575 | 0,30% | Akcje |
| RHUMBLINE ADVISERS | $102 294 748 | 257 527 | 0,30% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $101 464 685 | 255 437 | 0,30% | Akcje |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100 979 680 | 254 216 | 0,30% | Akcje |
| Gotham Asset Management, LLC | $89 318 889 | 224 860 | 0,27% | Akcje |
| Balyasny Asset Management L.P. | $87 965 958 | 221 454 | 0,26% | Akcje |
| FIRST TRUST ADVISORS LP | $85 094 587 | 214 226 | 0,25% | Akcje |
| Ensign Peak Advisors, Inc | $83 532 585 | 210 293 | 0,25% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83 463 866 | 210 120 | 0,25% | Akcje |
| Brandywine Global Investment Management, LLC | $80 388 706 | 313 859 | 0,24% | Akcje |
| California Public Employees Retirement System | $80 274 587 | 202 091 | 0,24% | Akcje |
| WOLVERINE TRADING, LLC | $76 135 109 | 298 300 | 0,23% | Opcja kupna |
| Camber Capital Management LP | $73 344 000 | 300 000 | 0,22% | Akcje |
| National Pension Service | $70 860 473 | 178 391 | 0,21% | Akcje |
| BARCLAYS PLC | $70 472 788 | 177 415 | 0,21% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $69 949 250 | 176 097 | 0,21% | Akcje |
| Walleye Trading LLC | $69 473 778 | 174 900 | 0,21% | Opcja kupna |
| CANADA PENSION PLAN INVESTMENT BOARD | $68 018 761 | 171 237 | 0,20% | Akcje |
| ARGA Investment Management, LP | $66 165 730 | 166 572 | 0,20% | Akcje |
| ORBIMED ADVISORS LLC | $65 183 802 | 164 100 | 0,19% | Akcje |
| Solel Partners LP | $64 742 888 | 162 990 | 0,19% | Akcje |
| AMF Tjanstepension AB | $61 961 951 | 155 989 | 0,18% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60 794 124 | 153 049 | 0,18% | Akcje |
| Perpetual Ltd | $57 945 659 | 145 878 | 0,17% | Akcje |
| CI INVESTMENTS INC. | $57 302 560 | 144 259 | 0,17% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $56 575 256 | 142 426 | 0,17% | Akcje |
| Squarepoint Ops LLC | $56 047 742 | 141 100 | 0,17% | Opcja sprzedaży |
| Aberdeen Group plc | $53 345 852 | 134 298 | 0,16% | Akcje |
| WOLVERINE TRADING, LLC | $52 653 949 | 206 300 | 0,16% | Opcja sprzedaży |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52 178 000 | 131 358 | 0,15% | Akcje |
| ING GROEP NV | $51 583 784 | 129 862 | 0,15% | Akcje |
| Squarepoint Ops LLC | $50 685 272 | 127 600 | 0,15% | Opcja kupna |
| Walleye Trading LLC | $49 573 056 | 124 800 | 0,15% | Opcja sprzedaży |
| D. E. Shaw & Co., Inc. | $46 514 462 | 117 100 | 0,14% | Opcja kupna |
| BRAIDWELL LP | $45 481 690 | 114 500 | 0,14% | Akcje |
| Jain Global LLC | $43 694 200 | 110 000 | 0,13% | Opcja sprzedaży |
| BANK OF MONTREAL /CAN/ | $43 207 208 | 108 774 | 0,13% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42 190 325 | 106 214 | 0,13% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42 127 167 | 106 055 | 0,13% | Akcje |
| AVIVA PLC | $41 509 093 | 104 499 | 0,12% | Akcje |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41 468 472 | 161 904 | 0,12% | Akcje |
| ROYAL BANK OF CANADA | $41 033 000 | 103 301 | 0,12% | Akcje |
| Pentwater Capital Management LP | $39 722 000 | 100 000 | 0,12% | Opcja kupna |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39 284 661 | 98 899 | 0,12% | Akcje |
| Point72 Asset Management, L.P. | $39 122 595 | 98 491 | 0,12% | Akcje |
| PFM Health Sciences, LP | $37 487 638 | 94 375 | 0,11% | Akcje |
| Summit Street Capital Management, LLC | $36 325 372 | 91 449 | 0,11% | Akcje |
| Columbus Hill Capital Management, L.P. | $35 501 935 | 89 376 | 0,11% | Akcje |
| Korea Investment CORP | $34 579 193 | 87 053 | 0,10% | Akcje |
| Quantinno Capital Management LP | $32 817 091 | 82 616 | 0,10% | Akcje |
| Fisher Funds Management LTD | $32 811 563 | 82 603 | 0,10% | Akcje |
| Swedbank AB | $32 034 603 | 80 647 | 0,10% | Akcje |
Insiderzy spółki 76 insiderów · 46 dyrektorzy generalni · 27 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 14 maja 2025 P | 30 474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 lutego 2024 A | 110 130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 24 lutego 2025 A | 29 676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 grudnia 2024 J | 20 165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 lutego 2021 A | 24 342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 9 maja 2014 G | 14 916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 27 marca 2025 J | 15 702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 24 lutego 2025 A | 16 234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 24 lutego 2025 A | 11 566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 lutego 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 grudnia 2022 M | 3 983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 grudnia 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 lutego 2014 A | 105 443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 marca 2017 J | 34 668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 24 lutego 2025 A | 8 628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 lutego 2025 A | 1 767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 24 lutego 2025 A | 11 266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 24 lutego 2025 A | 17 267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 lutego 2025 A | 16 717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 grudnia 2024 G | 7 111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 grudnia 2024 M | 14 015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 lutego 2024 A | 11 723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 lutego 2023 F | 3 687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 1 maja 2022 M | 4 294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 marca 2022 J | 5 723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 lutego 2022 F | 6 014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 marca 2021 G | 8 168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 grudnia 2019 M | 18 092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 grudnia 2019 M | 6 339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 lutego 2019 A | 9 774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 lutego 2019 M | 10 791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 grudnia 2018 M | 11 136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 grudnia 2018 M | 6 476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 marca 2017 M | 4 361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 lutego 2014 A | 1 101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 lutego 2014 A | 15 946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 czerwca 2013 M | 19 347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 grudnia 2012 G | 2 287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 kwietnia 2012 F | 11 946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 lutego 2012 A | 23 280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 4 lutego 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 marca 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 lutego 2008 F | 13 836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 grudnia 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 lutego 2007 M | 57 548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 6 stycznia 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Dyrektor | 30 czerwca 2026 A | 19 448 | 0 | 0 | $0 |
| Frank A Damelio | Dyrektor | 2 stycznia 2026 A | 20 634 | 0 | 0 | $0 |
| Karen Katz | Dyrektor | 31 grudnia 2025 A | 590 | 0 | 0 | $0 |
| David T Feinberg | Dyrektor | 30 czerwca 2025 A | 441 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| David A. Jones ×2 zgłoszenia | 12 listopada 2003 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 200 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 4,29% | 144 763 SH | 8 sierpnia 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,95% | 109 132 NS | 30 kwietnia 2026 | N-PORT |
| SMRI · EA Series Trust | 2,54% | 58 016 NS | 30 kwietnia 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,27% | 100 446 SH | 8 sierpnia 2026 | Dziennie |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,26% | 2 111 NS | 30 kwietnia 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 11 546 SH | 8 sierpnia 2026 | Dziennie |
| SRHQ · Elevation Series Trust | 1,63% | 13 322 NS | 30 kwietnia 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,60% | 32 564 SH | 8 sierpnia 2026 | Dziennie |
| CVAR · ETF Opportunities Trust | 1,51% | 2 473 NS | 30 kwietnia 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,20% | 225 NS | 30 kwietnia 2026 | N-PORT |
| ABCS · EA Series Trust | 1,19% | 441 NS | 29 maja 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,14% | 17 702 NS | 31 maja 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 0,96% | 17 434 NS | 30 kwietnia 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 52 223 NS | 30 kwietnia 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771 237 SH | 8 sierpnia 2026 | Dziennie |
| ITAN · EA Series Trust | 0,77% | 2 259 NS | 29 maja 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,72% | 65 925 NS | 31 maja 2026 | N-PORT |
| IYH · iShares Trust | 0,72% | 71 884 SH | 8 sierpnia 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 183 164 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,70% | 360 880 SH | 8 sierpnia 2026 | Dziennie |
| AUSF · Global X Funds | 0,70% | 19 401 NS | 31 maja 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,63% | 211 NS | 31 maja 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,59% | 30 459 NS | 30 kwietnia 2026 | N-PORT |
| IXJ · iShares Trust | 0,56% | 62 953 SH | 8 sierpnia 2026 | Dziennie |
| RXL · ProShares Trust | 0,53% | 1 258 NS | 31 maja 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,47% | 2 755 NS | 30 kwietnia 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2 601 869 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 55 439 NS | 30 kwietnia 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,45% | 28 340 NS | 30 kwietnia 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,43% | 3 849 NS | 29 maja 2026 | N-PORT |
| IWS · iShares Trust | 0,42% | 181 221 SH | 8 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,41% | 2 404 NS | 30 kwietnia 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,37% | 81 NS | 31 maja 2026 | N-PORT |
| IMCV · iShares Trust | 0,36% | 11 394 SH | 8 sierpnia 2026 | Dziennie |
| QARP · DBX ETF Trust | 0,36% | 887 NS | 29 maja 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,35% | 10 520 000 | 8 sierpnia 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,35% | 90 057 SH | 8 sierpnia 2026 | Dziennie |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,34% | 4 484 NS | 31 maja 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,34% | 1 004 NS | 31 maja 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,32% | 265 500 NS | 31 maja 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 7 839 SH | 8 sierpnia 2026 | Dziennie |
| IWR · iShares Trust | 0,32% | 489 015 SH | 8 sierpnia 2026 | Dziennie |
| IMCB · iShares Trust | 0,30% | 13 840 SH | 8 sierpnia 2026 | Dziennie |
| FNDB · SCHWAB STRATEGIC TRUST | 0,29% | 12 439 NS | 31 maja 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,29% | 2 779 NS | 30 kwietnia 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,28% | 1 250 NS | 31 maja 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,28% | 320 000 | 8 sierpnia 2026 | Dziennie |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,27% | 299 NS | 31 maja 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,26% | 12 272 NS | 30 kwietnia 2026 | N-PORT |
| VLUE · iShares Trust | 0,24% | 62 558 SH | 8 sierpnia 2026 | Dziennie |